Online ISSN: 3007-0244,
Print ISSN:  2410-4280
 



RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.

6440 3480 330 4230 10399 5756 7290 210 5757 2 2024 10.34689/SH.2024.26.2.019 Introduction. Thyroid cancer is one of the most common endocrine malignancies. Radioactive iodine I131 is the baseline drug in the therapy of patients with differentiated thyroid cancer (DTC); however, 5% to 15% of DTC and 50% of metastatic DTC are not amenable to radioactive iodine I131 therapy. Some patients suffer from recurrent disease after complex treatment. Recurrent disease is often resistant to radioiodine...

Изменен: 28.04.2024
Путь: Главная / Home / Publications
RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.

2 2024

Изменен: 28.04.2024
Путь: Главная / Публикации
Результаты поиска 1 2 из 2
Начало | Пред. | 1 | След. | Конец

Отсортировано по релевантности | Сортировать по дате